People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Biotechnology, Other Health Care, Other, Other Technology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Regado Biosciences Inc | — | Biotechnology | Series B | $141.7M | $793.8M | 2012 |
| Metabolon, Inc | — | Other Health Care | Series B | $123.6M | $42.1M | 2015 |
| Argos Therapeutics Inc | — | Biotechnology | Series B | $55.4M | $873.5M | 2010 |
| Veritas Collaborative Holdings, LLC | — | Other Health Care | Series A | $32.4M | $46.3M | 2017 |
| HyperBranch Medical Technology Inc | — | Other Health Care | Seed | $12.4M | $12.4M | 2009 |
| Aldagen Inc | — | Biotechnology | Series A | $9.5M | $21.1M | 2009 |
| Galaxy Diagnostics, Inc. | — | Biotechnology | Series A | $6.7M | $15.0M | 2023 |
| Matchwell, LLC | — | Other | Series A | $6.3M | $61.4M | 2018 |
| Quinsite, Inc. | — | Other Technology | Series A | $6.0M | $52.0M | 2023 |
| Essential Health Solutions Inc. | — | Healthtech | Series A | $4.1M | $92.8M | 2016 |
| Matchwell, Inc. | — | Other Health Care | Seed | $2.4M | $45.8M | 2021 |
| Pneumocyte LLC | — | Other Health Care | Pre-Seed | $600K | $1.8M | 2025 |
B. Jefferson Clark at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside B. Jefferson Clark on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.